BioSpace News Archive

Harrow Health, Inc., an ophthalmic-focused healthcare company, announced the closing of its underwritten registered public offering of $50 million aggregate principal amount of 8.625% senior notes due 2026.

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the closing of its initial public offering of 7,567,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase 987,000 additional shares of common stock, at the initial public offering price of $20.00 per share.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2021 after market close on Tuesday, May 4, 2021.

Businesses Can Order Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits Online or Through Labcorp Employer Services

First firm order reached with the Company for 2022 supply Israel also retains an option to purchase doses of variant-specific vaccine booster candidate, pending regulatory approval

Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Friday, May 7, 2021.

Kerecis®, the company that is pioneering the use of fish skin in tissue regeneration and wound care, announced its new product, Kerecis Omega3 GraftGuide™, at the 43rd Annual John A. Boswick Burn & Wound Care Symposium.

Medicure Inc. today reported its results from operations for the quarter and year ended December 31, 2020.

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that results from four clinical studies of the company’s three apoptosis-targeted drug candidates have been selected for presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.

Advanced Brain Monitoring, Inc. announces the discovery of two novel sleep biomarkers linked to neurodegenerative disease at the annual meeting of the American Academy of Neurology (AAN).